IP Library Granted Patent US 10,215,672
Granted Patent B2
US 10,215,672 · App. 15/363,250 · Granted Feb 26, 2019

Biocompatible method of functionalising substrates with inert surfaces

Inventors: Stephen Micheal Henry (Auckland, NZ); Stephen Robert Parker (Auckland, NZ)
Assignee: KODE BIOTECH LIMITED
G01N1/4077B01D65/08C08G64/42C12Q1/02C12Q1/24G01N33/54353G01N33/54393G01N2001/4088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,215,672
App. No.
15/363,250
Granted
Feb 26, 2019
Kind
B2
Abstract

Biocompatible methods of functionalizing inert surfaces for use in biological applications are described. The methods employ the use of synthetic constructs of the generic structure F-S-L (where F is a functional moiety, S is a spacer selected to provide a construct that is dispersible in water, and L is a diacyl- or dialkyl-glycerophospholipid). An object of the invention is to localize or immobilize functional moieties to the inert surface of a substrate wherein the surface is comprised of glass, silver, polyamide, polycarbonate, polypropylene, polyethersulfone, polytetrafluoroethylene or polyvinylidene fluoride, and the substrate is comprised of a fiber, membrane, microsphere or nanosphere.

Claims (11)

1. A method of localizing a functional moiety to the surface of a glass membrane by non-covalent interactions comprising the steps of:

immersing the glass membrane in an aqueous dispersion of a construct of the structure F-S-L; and then

washing the glass membrane with an aqueous vehicle to provide the functionalised surface,

wherein F is the functional moiety, S is a spacer selected to provide a construct that is dispersible in water, and L is a diacyl- or dialkyl-glycerophospholipid.

2. The method of claim 1 , wherein the glass membrane is a filtration membrane.

3. The method of claim 1 , wherein the construct is a water dispersible construct of the structure:

where M is a monovalent cation and R 1 and R 2 are independently a C 14-20 acyl, alkyl or alkenyl group.

4. The method of claim 3 , wherein the construct is a water dispersible construct of the structure:

where R 1 and R 2 are independently a C 13-19 alkyl or alkenyl group.

5. The method of claim 4 , wherein R 1 and R 2 are independently a C 15-17 alkyl or alkenyl group.

6. The method of claim 5 , wherein the construct is a water dispersible construct of the structure:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2017
From: HENRY, STEPHEN MICHEAL; PARKER, STEPHEN ROBERT
To: KODE BIOTECH LIMITED
Reel/Frame 042080/0774 →
Priority Claims (2)
NZ 597207 · Dec 19, 2011 · national
NZ 601745 · Sep 8, 2012 · national
Continuity (2)
Continuation 14366889
Related Publication 20170219467A1 · Aug 3, 2017